March 17, 2020 / 1:40 AM / in 22 days

BRIEF-FDA Provides More Regulatory Relief During Outbreak, Continues To Help Expedite Availability Of Diagnostics

March 16 (Reuters) - FDA

* U.S. FDA SAYS PROVIDES MORE REGULATORY RELIEF DURING OUTBREAK, CONTINUES TO HELP EXPEDITE AVAILABILITY OF DIAGNOSTICS

* US FDA SAYS UPDATED POLICY ON DIAGNOSTIC TESTING FOR CORONAVIRUS (COVID-19) IN ORDER TO ACHIEVE MORE RAPID TESTING CAPACITY IN U.S.

* FDA - PUTTING IN PLACE A POLICY FOR U.S. STATES TO TAKE RESPONSIBILITY FOR TESTS DEVELOPED AND USED BY LABORATORIES IN THEIR STATES

* FDA- UPDATED POLICY PROVIDES RECOMMENDATIONS FOR TEST DEVELOPERS WHO MAY WISH TO DEVELOP SEROLOGICAL TESTS FOR USE DURING CORONAVIRUS OUTBREAK

* FDA-TO NOT TO OBJECT TO COMMERCIAL MANUFACTURERS DISTRIBUTING,LABS USING NEW COMMERCIALLY DEVELOPED TESTS PRIOR TO AN EUA, UNDER CERTAIN CIRCUMSTANCES Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below